Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool December 5, 2008 Brian Orelli	Monsanto Ready to Round Up Growth The company announces that the European Union has approved its genetically modified soybean seeds for import.
The Motley Fool January 4, 2008 Brian Orelli	Monsanto Rounds Up Growth Sales grew 36% year-over-year at Monsanto; since sales growth significantly outpaced costs, the bottom line looked even better, with diluted EPS nearly tripling.
The Motley Fool June 29, 2011 Brian Orelli	Monsanto Is Back From the Dead Roundup makes a triumphant return, but investors should focus on the seed business.
The Motley Fool April 2, 2009 Brian Orelli	Monsanto Rounds Up Alternative Growth Forget Roundup. The agri-giant has a better plan.
The Motley Fool June 26, 2008 Brian Orelli	Why Throw Tomatoes at Monsanto? There wasn't a lot to complain about in Monsanto's third-quarter earnings report, but investors found enough disappointing news to send the stock down.
The Motley Fool January 11, 2012 Jacob Roche	Betting the Farm on Monsanto The biotech giant sits at the top of the food chain.
The Motley Fool January 8, 2009 Brian Orelli	Monsanto's Back! Monsanto blew the doors off Wall Street's estimates, and raised yearly guidance by 5% at the low end.
Registered Rep. April 1, 2006 Bob Hirschfeld	Good Breeding Ag-biotech is entering a period of vibrant growth as farmers, not only in the U.S., but Brazil, India and China increase usage of the highly productive seeds. Is Wall Street valuing shares of ag-biotech companies correctly?
The Motley Fool April 13, 2006 Brian Gorman	Monsanto's New Challenge The ag-biotech firm faces new competitive pressures from rivals and an ongoing wariness of GM crops in Europe.
BusinessWeek January 21, 2010 Jack Kaskey	Monsanto Will Let Bio-Crop Patents Expire Genetically engineered soybeans will go generic, but woe to anyone that crosses the seed giant on new products.
The Motley Fool August 6, 2009 Brian Orelli	No More Flower Power for Monsanto Monsanto sells its sunflower business to rival Syngenta for $160 million.
The Motley Fool May 27, 2008 Brian Orelli	Super Seed Swap Instead of continuing to fight each other in court, agribusiness companies Syngenta and Monsanto called a truce for their never-ending patent disputes last week.
The Motley Fool January 4, 2007 Brian Gorman	Monsanto's Bigger Harvest? High corn prices could allow Monsanto to raise seed prices and improve margins. Investors, take note.
The Motley Fool September 29, 2010 Brian Orelli	Monsanto's SmartStax Isn't Stacking Up It's hard to live up to the hype of SmartStax corn, which combines eight different traits to protect against bugs and make them resistant to herbicides used to kill weeds.
The Motley Fool May 28, 2009 Brian Orelli	Monsanto Plowed Down Low end of guidance is better than lowered guidance, I guess.
The Motley Fool September 28, 2005 Brian Gorman	Monsanto's Rich Pipeline The agrochemical giant's long-term health looks assured thanks to a rich product pipeline. Investors, take note.
The Motley Fool December 6, 2011 Neha Chamaria	Debugging Monsanto's Bug Concerns Doubts about Monsanto's pest-resistant seeds' efficiency grow. Should you become cautious?
The Motley Fool June 22, 2004 Brian Gorman	More Green for Monsanto The full-year earnings the agribusiness giant Monsanto may not please everyone, but the company plants roots for long-term success.
The Motley Fool April 3, 2008 Brian Orelli	Monsanto's Planting Its Seeds Strong growth from the agricultural giant, but will it last?
The Motley Fool January 6, 2010 Brian Orelli	Monsanto Needs to Round Up Some Growth Monsanto announces a $0.03 first-quarter loss compared with $1.00 per share of income a year ago. That's not exactly starting the year off on the right foot.
The Motley Fool October 8, 2009 Toby Shute	Monsanto's Solid Year in Seeds The agriculture giant closes the books on a fine year and looks forward.
The Motley Fool March 2, 2005 Brian Gorman	Monsanto's Brazil Benefit Brazil is on the cusp of legalizing genetically modified seed sales, a potential boon for Monsanto.
The Motley Fool July 17, 2007 Brian Orelli	A Fruitful Collaboration Monsanto and BASF team up to grow better plants. Long-term investors should take it as a sign that Monsanto and BASF are putting their capital to good use.
BusinessWeek April 29, 2010 Kaskey & Ligi	The Seed Makers Who Don't Pray for Rain Agricultural companies tweak crops to flourish with less.
The Motley Fool September 11, 2009 Brian Orelli	Monsanto Plowed Down Is it bad news, or a bad-news buy?
The Motley Fool June 24, 2009 Brian Orelli	The Death of a Cash Cow The company knew a drop in Roundup sales was coming with the patent expiring, but Monsanto has a backup plan.
The Motley Fool September 27, 2004 Brian Gorman	Monsanto Gets Tough The company is getting tough with some South American countries about its pirated technology. All the same, the company will have to maintain a diplomatic posture for its own sake.
The Motley Fool May 11, 2004 Brian Gorman	Monsanto's Fallow Wheat Field Monsanto halts development of its controversial genetically modified spring wheat.
The Motley Fool April 6, 2005 W.D. Crotty	Fast-Blooming Biotech Monsanto's net sales and net income soar in the second quarter. Is it time to buy this stock?
The Motley Fool September 3, 2008 Brian Orelli	Monsanto's Public-Relations Nightmare Agriculture giant Monsanto has to defend its patents without looking like it's picking on the little guy.
The Motley Fool September 16, 2008 Brian Orelli	Monsanto's Guidance Keeps Growing Monsanto announces another change in financial guidance, which fortunately continued the upward trend.
The Motley Fool May 6, 2009 Brian Orelli	Monsanto Kills the Love Monsanto announces that it's suing DuPont over a claimed misuse of Monsanto's herbicide-tolerant Roundup Ready technology.
The Motley Fool April 15, 2009 Brian Orelli	No Bumper Crop, but Bans Aplenty for Monsanto Germany's move to ban planting of Monsanto's genetically modified corn seeds won't be a major hit to sales, but it's the thought that counts.
The Motley Fool March 31, 2004 W.D. Crotty	Monsanto in the Balance Genetically modified crops are a boon for the company.
The Motley Fool December 7, 2009 Jordan DiPietro	How Terrible Is Monsanto? Monsanto, the global provider of agricultural products, finds its reputation being slammed in a recent food documentary, Food Inc. Which is Monsanto -- savior or sinner?
The Motley Fool March 29, 2005 Stephen D. Simpson	Monsanto Sows the Seeds of Growth The agricultural specialist hikes earnings guidance on the back of strong sales. The present valuation may look rich, but investors shouldn't underestimate this growing titan.
The Motley Fool September 14, 2011 Jacob Roche	Monsanto Is Getting a Bit Big for Its Britches The company plans to increase prices even while losing competitive advantages.
The Motley Fool January 19, 2010 Brian Orelli	Monsanto's Legal Wins Are Just the Beginning The lawyers may affect the stock price for a while.
The Motley Fool April 4, 2006 Rich Smith	Foolish Forecast: Monsanto Still Growing Although the winter quarter isn't usually strong for agriculture, Monsanto's rolling numbers support its CEO's assessment of the business. Over the past 18 months, the company has managed to grow its gross margins 60 basis points. Investors, take note.
The Motley Fool July 15, 2010 Brian Orelli	Insider Buying at Monsanto Monsanto's CEO and CFO bought shares. Should you?
The Motley Fool February 18, 2005 Brian Gorman	Monsanto Cottons to Emergent Monsanto's second acquisition in less than a month signals an aggressive move into cotton seeds. Investors will no doubt keep a close eye on this one.
The Motley Fool January 4, 2006 Stephen D. Simpson	Monsanto Harvests More Profits Growth is good today, and a strong pipeline speaks well for the future. While this stock doesn't look cheap at all by P/E standards, the cash flow picture is a somewhat different story.
The Motley Fool April 5, 2006 Stephen D. Simpson	This GM Actually Works Monsanto's path may be strewn with weeds, but rewards could still lurk within. This is a good company, and looks to be undervalued by a mid-teens percentage. Investors, take note.
The Motley Fool October 15, 2010 Tim Hanson	Monsanto's Pain Is Syngenta's Gain Monsanto may be down, but Syngenta and others in the sector are on the upswing.
The Motley Fool December 6, 2005 Brian Gorman	Monsanto's Trade Dividend The giant and competitors in agricultural biotechnology should enjoy rising sales in the developed world as subsidies come down. Investors, take note.
The Motley Fool March 26, 2008 Brian Orelli	Monsanto's Guidance Grows Like a Weed The company has had good reasons to set its sights higher. Can Monsanto's current upbeat news keep going strong?
The Motley Fool April 9, 2007 Ryan Fuhrmann	Scrutinizing Monsanto's Outlook Food for thought about what's driving Monsanto. Investors, in many respects, considering Monsanto is more akin to finding opportunities in biotechnology than looking into the heartland.
The Motley Fool July 15, 2009 Brian Orelli	Monsanto Goes Brown to Make Green The agricultural giant is buying WestBred, a privately held wheat breeding company for $45 million.
The Motley Fool December 15, 2009 Brian Orelli	Why Does Everyone Hate Monsanto? Sometimes the mean guy wins.
The Motley Fool December 5, 2006 Brian Gorman	Monsanto Needs to Charm The company has to confront concerns over genetically modified foods soon if it hopes to keep growing. Investors, take note.